FDA approves first treatment for CD55-deficient protein-losing enteropathy (CHAPLE disease) Veopoz (pozelimab-bbfg)

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-treatment-cd55-deficient-protein-losing-enteropathy-chaple-disease?utm_medium=email&utm_source=govdelivery